Treatment-driven tumour heterogeneity and drug resistance: Lessons from solid tumours
Treatment-driven tumour heterogeneity and drug resistance: Lessons from solid tumours is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Treatment-driven tumour heterogeneity and drug resistance: Lessons from solid tumours have?
Treatment-driven tumour heterogeneity and drug resistance: Lessons from solid tumours has 95 citations in the OpenAlex counts ScholarIQ stores.
When was Treatment-driven tumour heterogeneity and drug resistance: Lessons from solid tumours published?
Treatment-driven tumour heterogeneity and drug resistance: Lessons from solid tumours has 2022 year in the ScholarIQ index.
What is the open-access status of Treatment-driven tumour heterogeneity and drug resistance: Lessons from solid tumours?
Treatment-driven tumour heterogeneity and drug resistance: Lessons from solid tumours has green oa status in the ScholarIQ index.
What is the DOI of Treatment-driven tumour heterogeneity and drug resistance: Lessons from solid tumours?
The DOI for Treatment-driven tumour heterogeneity and drug resistance: Lessons from solid tumours is on the source record.
What is the PMID of Treatment-driven tumour heterogeneity and drug resistance: Lessons from solid tumours?
The PMID for Treatment-driven tumour heterogeneity and drug resistance: Lessons from solid tumours is on the source record.
What is the OpenAlex record for Treatment-driven tumour heterogeneity and drug resistance: Lessons from solid tumours?
The OpenAlex for Treatment-driven tumour heterogeneity and drug resistance: Lessons from solid tumours is on the source record.